Patrick Lamy - 10 Jan 2023 Form 3 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role: Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy
Signature: /s/ Jonathan Young, attorney-in-fact
Issuer symbol: AKRO
Transactions as of: 10 Jan 2023
Net transactions value: $0
Form type: 3
Filing time: 11 Jan 2023, 18:49:40 UTC
Next filing: 12 Dec 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney Senior Vice President, Commercial Strategy